Langdon L. Miller
Publications by Year
Research Areas
Chronic Lymphocytic Leukemia Research, Cancer therapeutics and mechanisms, Lymphoma Diagnosis and Treatment, Cancer Treatment and Pharmacology, Lung Cancer Research Studies
Most-Cited Works
- → Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer(2000)3,003 cited
- → Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia(2014)1,675 cited
- → PTC124 targets genetic disorders caused by nonsense mutations(2007)1,121 cited
- → PI3Kδ Inhibition by Idelalisib in Patients with Relapsed Indolent Lymphoma(2014)1,052 cited
- → Irinotecan Plus Gemcitabine Results in No Survival Advantage Compared With Gemcitabine Monotherapy in Patients With Locally Advanced or Metastatic Pancreatic Cancer Despite Increased Tumor Response Rate(2004)586 cited
- → Idelalisib, an inhibitor of phosphatidylinositol 3-kinase p110δ, for relapsed/refractory chronic lymphocytic leukemia(2014)583 cited
- → The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia(2011)547 cited
- → Exemestane Is Superior to Megestrol Acetate After Tamoxifen Failure in Postmenopausal Women With Advanced Breast Cancer: Results of a Phase III Randomized Double-Blind Trial(2000)525 cited
- → Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial(2008)387 cited
- → The 6‐minute walk test as a new outcome measure in Duchenne muscular dystrophy(2009)386 cited